pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Inside a Secret AI Startup: Challenges of Building and Selling Clinical Tools

Aug 12, 2026·read at STAT ↗Neutral

The STAT+ newsletter reveals that a health‑tech reporter has been quietly developing an artificial‑intelligence startup for the past six months.

The piece describes the difficulties of rapidly creating AI applications for clinics, including technical hurdles, regulatory uncertainty, and pressure from investors.

It also highlights concerns about how such tools might affect patient care and who ultimately benefits from their deployment.

The author invites readers to share feedback and tips for future investigations, emphasizing the ongoing nature of the project.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The secret AI-startup project I’ve been working on the last six months”

read at STAT ↗
478 words · retrieved 45m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: Definium Therapeutics says its LSD therapy eased anxiety in late-stage trialSTAT
  • 2h agoSTAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapiesSTAT
  • 4h agoSTAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health careSTAT
  • 4h agoOpinion: Climate change is making people with chronic illness even sickerSTAT
  • 4h agoSTAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts saySTAT